Evidence map›Paper›PMID 39732501›Full record

ArticleTobacco control2025

Eradication of commercial tobacco related disease and death.

Raglan Maddox, Rohan M Telford, Andrew Waa, Abbey Diaz, Shane Kawenata Bradbrook, Tom Calma, Lisa J Whop

Abstract read
In one paragraph

Article in Tobacco control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Cotinine Promotes Cancer Cell Proliferation and mEnvironment & health (Washington, D.C.) · 2026
    Article
  2. Article
  3. "Stealth Vaping Is Everywhere": The Narratives of Young Māori Adults in New Zealand.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  4. Two decades of global tobacco control: time for a rethink.Internal and emergency medicine · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Raglan MaddoxBagumani (Modewa) Clan, Alotau, Papua New Guinea Raglan.Maddox@anu.edu.au.ORCID 0000-0002-2770-0686
Rohan M TelfordNational Centre for Aboriginal and Torres Strait Islander Wellbeing Research, National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australian Capital Territory, Australia.
Andrew WaaNgāti Hine/Ngāpuhi, Wellington, New Zealand.ORCID 0000-0002-8078-0283
Abbey DiazFirst Nations Cancer and Wellbeing Research Program, School of Public Health, The University of Queensland, Saint Lucia, Queensland, Australia.
Shane Kawenata BradbrookNgāi Tāmanuhiri, Rongowhakaata, Ngāti Kahungunu, Aotearoa, New Zealand.
Tom CalmaElder from the Kungarakan tribal group and a member of the Iwaidja tribal group, Northern Territory, Northern Territory, Australia.
Lisa J WhopNational Centre for Aboriginal and Torres Strait Islander Wellbeing Research, National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australian Capital Territory, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The eradication of the commercial tobacco industry is a crucial goal for health and well-being, particularly from a public health and health justice perspective. The term 'eradication' is applied in epidemiology to mean the process and outcome of elimination of the-commercial tobacco industry as a human-made-agent of disease and death. In this commentary, we outline why the eradication of the tobacco industry is necessary, urgent and realistic.The potential impact of eradication of the industry is substantial. Without the industry and the commercial tobacco that it produces, it is expected that globally over 22 000 lives will be saved daily (over 8 million annually), and life expectancy will increase. The human right to health underscores the need for tobacco industry accountability for the harms it causes and given the enormous human and financial costs, it is time for action towards eradication of the industry.The tobacco industry's opposition to tobacco control, particularly strategies focused on market supply and industry reform, has been fierce. Their strategies have involved circumventing, attacking and undermining public health measures to preserve profits. However, with insights learnt from over 70 years of incremental successes in reducing commercial tobacco use, we know that through comprehensive and locally tailored eradication strategies involving legislation, regulation and public health initiatives across multiple levels of governments, we can overcome the resistance from the tobacco industry and their affiliates. Given the cost of commercial tobacco and the ever-growing global consensus on its harms, the time to act is now.

Indexed as

CommerceSmoking PreventionTobacco IndustryTobacco ProductsHumansPublic HealthDenormalisationEnd gameGlobal healthPublic policyTobacco industry

Identifiers

PMID39732501
PMCPMC12772599

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.